ANSWERS · RESULTS
A trial average is not a personal promise
MYTH.Semaglutide means a guaranteed amount of weight loss.
FACT.Trials describe averages across groups. One person may lose more, less or no weight, and the trial setting matters.
What the STEP 1 study measured
In the STEP 1 trial, 1,961 adults with obesity, or overweight plus a weight-related condition, and without diabetes took part.
At week 68, people on semaglutide plus diet and exercise support had lost 14.9% of their body weight on average. People on a placebo, a dummy shot with no medicine, plus the same support lost 2.4%.
The trial result combines the medicine with regular study visits and diet and exercise support. It does not describe every patient seen in routine care.
What happened after treatment stopped
In a follow-up study of 327 people from STEP 1, people regained about two-thirds of the weight they had lost during the year after semaglutide and the study’s diet and exercise support stopped.
That finding describes a study group. It does not decide how long any one person stays on treatment.
How to read a result claim
Look for the comparison group, the length of the study, who was included, what other support was provided and whether the number is an average.
Then ask what the claim leaves out. A percentage without a time period is only half a result.
ANNOTATED READING LIST
Evidence, with a note on why it belongs
- The main semaglutide weight trial.The short summary at the top of the published report gives the number of people, what the medicine was compared with and the average result.
- Follow-up study after treatment ended.This follow-up study tracked some of the same people after treatment ended.